We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Liquid Biopsies – News and Features

News

Prostate Cancer Foundation Funds $1 Million in new Creativity Awards for Advanced Research

Initial funding gives boost to 10 innovative projects to accelerate advances against prostate cancer.
News

Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009

Veridex announces that the CellSearch® technology to measure CTCs is ranked as the top medical innovation for 2009 by the Cleveland Clinic.
News

Hollis-Eden Commences Phase I/II Clinical Trial with APOPTONE™ in Late-Stage Prostate Cancer Patients

The open-label dose ranging study, being conducted with the Prostate Cancer Clinical Trial Consortium will evaluate the safety, tolerance and pharmacokinetics of APOPTONE.
News

Circulating Tumor Cells can Reveal Genetic Signature of Dangerous Lung Cancers

MGH-developed device promises improvements in targeted therapy, treatment monitoring.
News

CytoGenix Completes synDNA™ Supply Agreement

CytoGenix announce the completion of the first Supply Agreement to provide DNA products to one of its customers.
News

Bristol-Myers Squibb Awards Immunicon Research Services Agreement for Oncology Biomarker Development

The research agreement between Immunicon and Bristol-Myers Squibb involve protein and molecular targets associated with circulating tumor cells.
News

Researchers Describe Gene’s Role in Breast Cancer

Analysis of breast-cancer gene role offers promising target for drugs to stop or slow progression of the disease.
News

AstraZeneca and The University of Manchester Work with DxS on a Clinical Pharmacology Collaboration

Research project aims to assess correlation between circulating DNA and primary tumours.
News

CytoGenix Announces Completion of synDNA™ Production Module Prototype

The device was designed for the commercial production of cell-free DNA.
News

Clarient Inc. and Health Discovery Corporation Jointly Announce Licensing Agreement

Clarient licenses HDC's Support Vector Machine patent portfolio in the field of peripheral rare cell detection.
Advertisement